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Abstract The evolutionarily conserved factor eIF5A is the only
protein known to undergo hypusination, a unique posttransla-
tional modi¢cation triggered by deoxyhypusine synthase (Dys1).
Although eIF5A is essential for cell viability, the function of this
putative translation initiation factor is still obscure. To identify
eIF5A-binding proteins that could clarify its function, we
screened a two-hybrid library and identi¢ed two eIF-5A part-
ners in S. cerevisiae : Dys1 and the protein encoded by the gene
YJR070C, named Lia1 (Ligand of eIF5A). The interactions
were con¢rmed by GST pulldown. Mapping binding sites for
these proteins revealed that both eIF5A domains can bind to
Dys1, whereas the C-terminal domain is su⁄cient to bind
Lia1. We demonstrate for the ¢rst time in vivo that the N-ter-
minal K-helix of Dys1 can modulate enzyme activity by inhibit-
ing eIF5A interaction. We suggest that this inhibition be abro-
gated in the cell when hypusinated and functional eIF5A is
required.
0 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The putative translation initiation factor 5A (eIF5A) is an
intriguing protein. It was identi¢ed 25 years ago and impli-
cated in protein synthesis but while subsequent work has re-
vealed its importance in eukaryotic cells, its function remains
unclear. eIF5A is the only protein that contains the essential
amino acid hypusine, formed by a posttranslational modi¢ca-
tion of a speci¢c lysine. Hypusination is a two-step process
catalyzed consecutively by deoxyhypusine synthase (Dys1)
and deoxyhypusine hydroxylase [1]. eIF5A and Dys1 are
highly conserved throughout evolution, being found in all
eukaryotic cells and archaea but not in eubacteria [2]. Yeast
eIF5A is 63% and 35% identical to the mammalian and ar-
chaea proteins respectively. These similarities allow heterolo-
gous eIF5A to be functional in yeast [3]. Also, yeast Dys1 is
59% identical to the human protein and 44% to the archaeal
homolog.
In Saccharomyces cerevisiae, eIF5A is encoded by the essen-
tial gene TIF51A in aerobic conditions [4]. eIF5A is a small
abundant protein that localizes mainly in the cytoplasm [5,6].
The hypusine residue (residue 51 in S. cerevisiae) is essential
for eIF5A function since the alteration of lysine 51 to arginine
(eIF5AK51R) blocks eIF5A hypusination and abolishes protein
function in vivo [4]. The eIF5A protein comprises two well-
de¢ned domains: the N-terminal domain is folded in a L-roll
architecture and the C-terminal domain is organized in a
L-barrel structure. The N-terminal domain bears the hypusine
residue in an exposed loop [7]. Dys1 is a tetramer of four
identical subunits of 43 kDa encoded by the essential gene
DYS1 in S. cerevisiae and has a very high a⁄nity for its
substrate [8^10].
The importance of eIF5A in the cell is evident because it is
essential for cell viability and highly conserved throughout
evolution. In addition, the critical role of the hypusine residue
is clear because this unique posttranslational modi¢cation is
absolutely required for protein function in vivo. However,
even after almost three decades of study, its function is still
obscure. Initially, eIF5A was characterized as a translation
initiation factor [11]. Nevertheless, its depletion in yeast re-
sulted in a slight decrease (30%) in protein synthesis, arguing
against eIF5A being considered a general translation initiation
factor [12]. It was hypothesized that eIF5A might have a role
in the translation of a speci¢c subset of mRNAs, for instance
those related to the G1/S cell cycle transition. This hypothesis
was raised because eIF5A depletion results in an increase of
G1-arrested cells [1,12]. Also, hypusine formation is essential
for proliferation of mammalian cell lines [13^15]. eIF5A has
also been associated with mRNA export acting as a cofactor
of Rev, an HIV-1 shuttling protein [16]. However, the nucle-
ocytoplasmic shuttling property of eIF5A has been questioned
in a series of protein localization experiments [5]. Moreover,
yeast cells de¢cient in the nuclear export machinery eIF5A
localization remains mainly cytoplasmic, whereas Rev is re-
tained in the nucleus [6]. eIF5A also participates in the
mRNA decay process since eIF5A mutants accumulate tran-
scripts at the restrictive temperature [6,17]. Thus, eIF5A has
been associated with several steps of RNA metabolism but its
function remains unclear.
In this study we sought to identify eIF5A-interacting pro-
teins that could help us to understand its role in the cell. As
expected, a two-hybrid screen of a cDNA library identi¢ed
several clones containing DYS1. However, we also identi¢ed
a new eIF5A-interacting factor, the protein encoded by the
gene YJR070C, which we have called Lia1 (Ligand of eIF5A).
We have mapped the eIF5A binding sites for both Lia1 and
Dys1. Finally, we have shown that, in vivo, the N-terminal
K-helix of Dys1 can regulate the interaction of Dys1 with its
substrate eIF5A. This regulation could be under control of
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a cellular mechanism triggered to make hypusinated and func-
tional eIF5A available in the cell.
2. Materials and methods
2.1. Plasmid construction
The plasmid expressing the bait protein lexA-eIF5A (pSV278,
TRP1) was constructed as follows: TIF51A was PCR ampli¢ed and
cloned into pBTM116 BamHI site. GST^eIF5A expressing plasmid
was achieved by cloning TIF51A gene into the vector pPS892 [18];
TIF51A was PCR ampli¢ed and inserted into pPS892 BamHI^SalI
sites. For the expression of GST^eIF5AK51R in yeast, a 281 bp
SalI^BstEII fragment of the plasmid Yep352T-5A(K51R) [4], contain-
ing the TIF51AK51R allele, was swapped with the corresponding frag-
ment in the plasmid pPS892-TIF51A described above. Truncations in
eIF5A were constructed as lexA fusion proteins using pSV278. The
enzyme HincII was used for the deletion v1-42 (pSV429). The deletion
v1-63 (pSV420) was obtained with EcoRV. To the deletion v1-90
(pSV421) MfeI was used. The enzymes MfeI and AluI were used for
the v90-152 deletion (pSV422). To express GST^Lia1 in yeast
(pSV361), LIA1 was subcloned from pGEX-LIA1 (pSV356) into
pPS892. Plasmid constructions were con¢rmed by DNA sequencing.
2.2. Two-hybrid screen
A two-hybrid screen was performed in the S. cerevisiae L40 strain
that carries the HIS3 and lacZ reporter genes [19]. Expression of the
bait protein (lexA-eIF5A) in L40 was con¢rmed by western blot using
anti-eIF5A. L40/lexA-eIF5A was transformed with a yeast cDNA
library fused to the GAL4 activation domain (pACT, LEU2, ATCC
87002) and plated on selective medium (3Leu/Trp/His) for candidate
selection. The Hisþ clones were further assayed for L-gal activity [20].
LEU2 cDNA library plasmids from Hisþ/L-galþ transformants were
isolated in E. coli HB101 strain (LeuB mutation). The LEU2 plasmid
was reintroduced by transformation into L40/lexA-eIF5A strain for
plasmid linkage. The positive clones (Hisþ/L-galþ) had the extremities
of their LEU2 plasmid sequenced and the gene present in each clone
was identi¢ed using the S. cerevisiae Genome Database.
2.3. GST pulldown assay
Plasmids expressing GST^eIF5A, GST^eIF5AK51R, GST^Dys1 and
GST^Lia1 were introduced in the wild type strain FY23. The resulting
strains were used for GST pulldown. Brie£y, cells were grown at 30‡C
to OD600nm = 0.4 and production of GST fusion proteins was induced
with 2% galactose for 3 h. Cells were collected, washed twice in cold
PBS and suspended in cold Bu¡er A (30 mM HEPES, pH 7.5, 100
mM KAc, 2 mM MgAc, 7 mM L-mercaptoethanol, 5 Wg/ml of pep-
statin, leupeptin, aprotinin and chymostatin). Cells were broken by
vortex agitation with glass beads for 3 min, incubating the tubes on
ice bath for 1 min after every 1 min agitation. Cell lysates were
clari¢ed by centrifugation at 20 000Ug for 20 min at 4‡C, and the
total protein concentration was determined. Clari¢ed lysates (2 mg)
were incubated with 100 Wl of glutathione-Sepharose beads (50%
slurry) for 1 h, at 4‡C. Beads were collected, washed ¢ve times with
cold Bu¡er A and suspended in 30 Wl of SDS^PAGE loading bu¡er.
Proteins were separated by 12% SDS^PAGE, transferred to nitro-
cellulose membrane, stained with Ponceau-S and documented after
rinsing. Finally, proteins were detected by western blot using the poly-
clonal anti-eIF5A, anti-Dys1 or anti-Lia1 and the ECL system (Amer-
sham).
3. Results and discussion
3.1. Identi¢cation of eIF5A cellular partners: Dys1 and Lia1
In an attempt to understand the role of eIF5A in the cell,
we searched for proteins that physically interact with eIF5A.
Fig. 1. eIF5A cellular partners revealed by two-hybrid. The strain
L40/lexA-eIF5A containing pACT (negative control), the positive
control L40-41 [21], pACT-Dys1 or pACT-Lia1 were grown on
3Leu/Trp to OD600nm = 0.5. Cells were collected by centrifugation
and suspended in one tenth of the original volume. Ten-fold serial
dilutions of these cell suspensions were spotted (4 Wl) onto 3Leu/
Trp and 3Leu/Trp/His plates and incubated at 30‡C for 2 days.
For L-gal activity ¢lter assay, 3 Wl of the concentrated cell suspen-
sions were dropped onto a nitrocellulose ¢lter laying on top of a
3Leu/Trp plate and incubated 24 h at 30‡C before the assay.
Fig. 2. Con¢rmation of eIF5A two-hybrid interactions by copuri¢-
cation. Western blot of GST pulldown assays (upper panels) and in-
put of GST or GST fusion proteins (lower panels). A: Copuri¢ca-
tion of Dys1 with GST^eIF5A (lane 2) and GST^eIF5AK51R (lane
3). B: Copuri¢cation of eIF5A with GST^Dys1 (lane 2). C: Copuri-
¢cation of eIF5A with GST^Lia1 (lane 2). GST negative control is
shown in lane 1 of all panels. Arrowheads indicate GST or GST fu-
sions and copuri¢ed proteins are indicated by arrows.
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We screened a yeast two-hybrid cDNA library (1.1U106
transformants) and 14 positive clones were isolated. DYS1
was the most frequent gene as it was present in 10 out of
the 14 positive clones (Fig. 1). Although this interaction has
not been described in S. cerevisiae, the physical interaction
between eIF5A and Dys1 has been demonstrated in vitro
for the human proteins [10]. The remaining four clones
(30%) contained the gene YJR070C, suggesting that it encodes
a speci¢c and signi¢cant eIF5A-interacting protein. Here, we
named the YJR070C gene LIA1, because it encodes a protein
‘Ligand of eIF5A’. As shown in Fig. 1, the eIF5A interaction
with Lia1 is not as intense as with Dys1. Lia1 is a protein of
325 amino acids (36 kDa), not essential for cell viability [22].
Lia1 has a cytoplasmic subcellular localization [23] and con-
tains four to ¢ve HEAT-like repeats.
GST pulldown assays were performed to con¢rm these in-
teractions using wild type yeast cells expressing the fusion
proteins GST^eIF5A, GST^eIF5AK51R, GST^Lia1 or GST^
Dys1. The fusion proteins were puri¢ed by glutathione-Se-
pharose and the copuri¢ed proteins revealed by western
blot. GST^eIF5A copuri¢ed Dys1 but not GST alone (Fig.
2A). This fusion protein (GST^eIF5A) is functional as it res-
cues the temperature-sensitive phenotype of an eIF5A mutant
(data not shown). In a similar experiment, eIF5A was also
copuri¢ed with GST^Dys1 protein (Fig. 2B). The copuri¢ca-
tion of Dys1 with the non-functional isoform eIF5AK51R was
as intense as with the wild type protein (Fig. 2A), indicating
that this amino acid alteration does not impair eIF5A binding
to the modifying enzyme, even though it cannot be hypusi-
nated. GST^Lia1 but not GST alone copuri¢es eIF5A (Fig.
2C). On the other hand, GST^eIF5A copuri¢es small
amounts of Lia1, assayed using anti-Lia1 (data not shown);
this could be due to the fusion of Lia1 to GST or to the low
expression of Lia1 in the cell.
The two-hybrid system is a valuable tool for de¢ning pro-
tein function through the establishment of a protein interac-
tion network with other well-known proteins. However, in
this study the only protein found in the screen besides the
expected Dys1 was the protein Lia1. Even though eIF5A is
an essential protein, Lia1 is not required for cell viability.
Overexpression of Lia1 does not suppress a temperature-sen-
sitive allele of eIF5A and this allele is not synthetically lethal
with a knockout strain of LIA1 (data not shown). Due to the
fact that Lia1 is not a well-characterized protein, further stud-
ies will be required to establish the functional relevance of this
interaction.
3.2. Mapping eIF5A-binding sites to Dys1 and Lia1
To de¢ne which domain of eIF5A is required for the inter-
actions with Dys1 and Lia1, three N-terminal deletions and
one deletion of the C-terminal half of eIF5A (Fig. 3A) were
created. The truncation sites are indicated in the predicted
structure for the human eIF5A (Fig. 3B) [7]. Expression of
the truncated lexA^eIF5A proteins, with the expected molec-
ular sizes, was con¢rmed by western blot using anti-eIF5A
(data not shown). The interactions were assayed by the ex-
pression of the two-hybrid HIS3 reporter gene. The interac-
tion of eIF5A with Dys1 was analyzed using one of the stron-
gest interacting clones selected in the screen Dys1(K29) which
does not contain the ¢rst 28 amino acids of Dys1. Binding of
eIF5A to Dys1(K29) was not a¡ected by truncation of either
the N- or the C-terminal half (see v1-90 and v90-152, Fig.
Fig. 3. Determining eIF5A binding sites for Dys1 and Lia1. A: eIF5A truncations scheme. B: Predicted tertiary structure for the human
eIF5A [7]. Arrows indicate the position of the corresponding amino acid in the yeast protein and the truncation sites. C: L40 strains expressing
vector alone (3), wild type eIF5A (+) or eIF5A truncations (v1-42, v1-63, v1-90 and v90-152) fused to lexA and Dys1 fused to Gal4-activa-
tion domain were tested exactly as described in Fig. 1, except that the expression of HIS3 reporter was observed in selective medium containing
1 mM 3-aminotriazole. D: L40 strains expressing vector alone (3), wild type eIF5A (+) or eIF5A truncations fused to lexA and Lia1 fused to
Gal4-activation domain were tested exactly as described in Fig. 1.
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3C), suggesting that both domains of eIF5A can interact with
Dys1. Thus, although the target site is located in the N-ter-
minal domain, the modifying enzyme interacts with both do-
mains of eIF5A. The truncation of eIF5A residues 1^42 or
1^63 weakens the interaction with Dys1 probably due to a
conformational change in eIF5A structure, suggesting that
the correct folding of the N-terminal domain of eIF5A is
essential for e⁄cient interaction with Dys1. The eIF5A N-ter-
minal domain is su⁄cient for hypusination by Dys1 with a
slight reduction of 24% when compared to hypusination e⁄-
ciency of the native protein [8]. Although binding to the
N-terminal domain is enough to permit hypusination, the in-
teraction with C-terminal domain of eIF5A identi¢ed here
might be important for the complete enzymatic activity.
The interaction with Lia1 was mapped to the C-terminal
domain of eIF5A (Fig. 3D). None of the N-terminal trunca-
tions a¡ected Lia1 binding to eIF5A. In contrast, the C-ter-
minal deletion (v90-152) completely abolished the interaction.
Although the N-terminal domain su⁄ces for eIF5A hypusi-
nation [8], this domain is not functional by itself as it cannot
substitute for the native protein in a knockout strain (data not
shown). The signi¢cance of the eIF5A C-terminal domain for
protein function is further highlighted by the fact that temper-
ature-sensitive alleles of eIF5A with amino acid alterations in
this domain have a more severe phenotype than alleles altered
in the N-terminal domain [6,17]. Hence, the C-terminal do-
main must have an important role in eIF5A function and Lia1
might contribute to this function.
3.3. Dys1 N-terminal domain impairs eIF5A binding
During the analysis of the positive clones, we observed that
the DYS1 clones exhibited an irregular growth pattern, vary-
ing from very poor to normal growth (data not shown). Se-
quencing of all 10 DYS1 cDNAs revealed several 5P-end trun-
cations encoding Dys1 proteins starting at the following
residues: aspartate 3 (D3), proline 9 (P9), leucine 12 (L12)
and lysine 29 (K29). Interestingly, the protein encoded by a
82 nt deletion (K29) showed the strongest interaction with
eIF5A, whereas a deletion of 24 nt (P9) or the entire gene
(M1) resulted in a weakened interaction (Fig. 4A). Given that
yeast Dys1 is 79% similar to the human protein, we used the
crystal structure of the human Dys1 monomer [24] to locate
the corresponding residues in these truncated forms of yeast
Dys1. As shown in Fig. 4B, the truncated protein Dys1(K29)
has the ¢rst N-terminal K-helix removed, whereas Dys1(P9)
maintains this secondary structure. It was previously deter-
mined that the enzyme tetramer is formed by two pairs of
tightly associated dimers which contain two active sites lo-
cated at each dimer interface. The active site is buried inside
a cavity and the N-terminal K-helix of a third monomer ob-
structs the active site entrance [24]. We found that clones
containing the entire protein Dys1(M1) or a small truncation
of Dys1(P9) have decreased interaction with eIF5A compared
to the truncation that lacks the blocking N-terminal K-helix
Dys1(K29). Therefore, the Dys1(K29) interaction probably
re£ects the total binding capacity to eIF5A since the entrance
of the active site is uncovered.
Knowing that the N-terminal K-helix of Dys1 blocks eIF5A
binding (Fig. 4A) and Dys1(K29) binds to both domains of
eIF5A (Fig. 3C), we wondered if the inhibitory N-terminal
K-helix interferes in the interaction of Dys1 with both
eIF5A domains. To answer this question, we transformed
the L40 strain with the LEU2 plasmids expressing Dys1(M1)
and the TRP1 plasmids expressing eIF5A v1-90 or v90-152
and tested for the expression of the HIS3 two-hybrid reporter
gene. In Fig. 4C, we demonstrated that the interaction of
Dys1 with the eIF5A C-terminal domain (v1-90) is not af-
fected by the presence of the blocking K-helix. However, as
expected, the Dys1 interaction with the eIF5A N-terminal
domain (v90-152) is completely abolished in the presence of
the blocking K-helix. These results demonstrate that each
eIF5A domain has an independent binding site in the enzyme.
Here, we present for the ¢rst time in vivo evidence for the
inhibitory e¡ect of the Dys1 N-terminal K-helix on the inter-
action with its substrate eIF5A. This helix seems to modulate
eIF5A Lys51 access to the active site [24]. These ¢ndings may
suggest a mechanism where inactive Dys1 under negative con-
trol of the N-terminal K-helix would open the catalytic site
only when hypusinated and functional eIF5A is needed in the
cell, for instance, during cell cycle transition. Future work will
address the question if this mechanism is under control of one
of the signal transduction pathways governing cell prolifera-
tion.
Fig. 4. In vivo inhibitory e¡ect of the N-terminal K-helix on Dys1
interaction to eIF5A. A: Expression of HIS3 reporter gene as de-
scribed in Fig. 3C. Dys1(M1)= entire Dys1, Dys1(P9) and Dys1-
(K29)= truncated forms of Dys1. B: Tertiary structure of human
Dys1 [24]. Location of the starting amino acid in the truncated
forms of Dys1 is indicated by arrows. C: Interaction of Dys1(M1)
to either eIF5A domains: N-terminal (v90-152) and C-terminal (v1-
90).
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